Psychedelics Then and Now with Zach Leary
Episode 72 - Jamie Wheal: Psychedelics and Human Optimization
Feb 2, 2024
Jamie Wheal, author of 'Stealing Fire' and founder of the Flow Genome Project, dives into the synergy of psychedelics and human optimization. He discusses the clash between authenticity and commercialization in the psychedelic movement. Wheal emphasizes the significance of community, structured rites of passage, and shared psychotechnologies over solitary experiences. He challenges listeners to navigate the evolving landscape of meaning in society, advocating for grassroots solutions and healthy leadership dynamics within community frameworks.
01:14:51
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The recent FDA submission for MDMA therapy signifies a hopeful milestone for mental health treatment through psychedelics.
- Understanding avidya highlights the importance of self-awareness and the distinction between personality and soul in personal growth.
Deep dives
MDMA as a Treatment for PTSD
The recent submission of a new drug application to the FDA for MDMA as a treatment for PTSD marks a significant milestone in the field of psychedelics. This development comes as part of MAPS' ongoing efforts to address mental health issues through psychedelic research. With plans to roll out MDMA therapy potentially within the next year, this step signifies hope for individuals suffering from trauma. The rebranding of the MAPS Public Benefit Corporation as Lycos Therapeutics is also noted as a strategic move to strengthen its mission and outreach.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
